DarioHealth Corp. Watch

from 8-K 77 pages Credit Agreement Among DarioHealth Corp. as Borrower, Callodine Commercial Finance, LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the Financial Institutions Party Hereto From Time to Time as Lenders Dated as of April 30, 2025

from 8-K 9 pages Third Amendment to Loan and Security Agreement and Supplement

from 8-K 13 pages First Amendment to Loan and Security Agreement and Supplement

from 8-K 43 pages Loan and Security Agreement Dated as of May 1, 2023 Between DarioHealth Corp., a Delaware Corporation (“Company”), Psyinnovations, Inc., a Delaware Corporation as a Borrower (Together With Company, Each Individually, a “Borrower”, and Collectively, “Borrower”) Labstyle Innovation Ltd., an Israeli Private Company, Company #514668466 (“Guarantor” or “Israeli Subsidiary”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership, (“Avenue 2”), as a Lender, and Avenue Venture Opportunities Fund, L.P., a Delaware Limited Partnership (“Avenue”) as Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and as a Lender (In Such Capacity, Together With Avenue 2, a “Lender” and Collectively, the “Lenders”) Loan and Security Agreement

from 8-K 81 pages Credit Agreement Dated as of June 9, 2022 by and Between DarioHealth Corp., as the Borrower, and Orbimed Royalty and Credit Opportunities III, LP, as the Lender